Centrum Medyczne Enel Med SA Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Dec'23

Sep'23

Net Sales

204.68

191.96

184.40

181.79

177.44

164.68

156.40

Other Operating Income

0.00

Total Operating income

204.68

191.96

184.40

181.79

177.44

164.68

156.40

Raw Material Cost

186.44

176.47

164.92

168.74

167.39

156.69

148.28

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

2.32

4.44

2.71

2.21

2.51

3.30

0.97

Selling and Distribution Expenses

12.39

10.85

8.46

8.26

8.12

8.50

8.73

Other Expenses

-0.23

-0.44

-0.27

-0.22

-0.25

-0.33

-0.10

Total Expenditure (Excl Depreciation)

198.83

187.31

173.39

176.99

175.51

165.19

157.01

Operating Profit (PBDIT) excl Other Income

5.8

4.6000000000000005

4.8

1.9

-0.5

-0.6

Other Income

4.52

0.21

6.73

-0.62

2.39

14.08

-3.60

Operating Profit (PBDIT)

30.10

24.20

36.65

23.03

22.88

31.51

13.97

Interest

2.32

4.44

2.71

2.21

2.51

3.30

0.97

Exceptional Items

0.00

Gross Profit (PBDT)

18.24

15.49

19.48

13.06

10.05

8.00

8.11

Depreciation

19.73

19.35

18.91

18.84

18.56

17.93

18.19

Profit Before Tax

8.04

0.41

15.03

1.97

1.81

10.28

-5.19

Tax

1.89

0.81

2.40

0.07

0.46

2.53

-1.17

Provisions and contingencies

0.00

Profit After Tax

6.15

-0.40

12.63

1.90

1.36

7.74

-4.02

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

6.15

-0.40

12.63

1.90

1.36

7.74

-4.02

Share in Profit of Associates

0.00

Minority Interest

0.00

Other related items

0.00

Consolidated Net Profit

6.15

-0.40

12.63

1.90

1.36

7.74

-4.02

Equity Capital

0.00

Face Value

1.0

Reserves

178.95

172.74

173.28

163.70

159.46

160.34

152.58

Earnings per share (EPS)

0.22

-0.01

0.45

0.07

0.05

0.27

-0.14

Diluted Earnings per share

0.22

-0.01

0.45

0.07

0.05

0.27

-0.14

Operating Profit Margin (Excl OI)

2.86%

2.42%

5.97%

2.64%

1.09%

-0.31%

-0.4%

Gross Profit Margin

13.57%

10.29%

18.41%

11.45%

11.48%

17.13%

8.31%

PAT Margin

3.01%

-0.21%

6.85%

1.05%

0.76%

4.7%

-2.57%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2025 is 6.61% vs 4.12% in Dec 2024

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2025 is 1,650.00% vs -103.17% in Dec 2024

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2025 is 6.67% vs -19.73% in Dec 2024

Interest

QoQ Growth in quarter ended Mar 2025 is -47.73% vs 62.96% in Dec 2024

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2025 has improved from Dec 2024

Compare Quarterly Results Of Centrum Medyczne Enel Med SA With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(PLN)

Change(%)

Net Sales

204.68

157.85

46.83

29.67%

Other Operating Income

0.00

Total Operating income

204.68

157.85

46.83

29.67%

Raw Material Cost

186.44

116.37

70.07

60.21%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

20.85

-20.85

-100.00%

Power Cost

0.00

Manufacturing Expenses

2.32

2.81

-0.49

-17.44%

Selling and Distribution Expenses

12.39

8.03

4.36

54.30%

Other Expenses

-0.23

-2.37

2.14

90.30%

Total Expenditure (Excl Depreciation)

198.83

124.40

74.43

59.83%

Operating Profit (PBDIT) excl Other Income

5.85

33.45

-27.60

-82.51%

Other Income

4.52

-0.08

4.60

5,750.00%

Operating Profit (PBDIT)

30.10

46.45

-16.35

-35.20%

Interest

2.32

2.81

-0.49

-17.44%

Exceptional Items

0.00

-0.07

0.07

100.00%

Gross Profit (PBDT)

18.24

41.48

-23.24

-56.03%

Depreciation

19.73

13.28

6.45

48.57%

Profit Before Tax

8.04

30.30

-22.26

-73.47%

Tax

1.89

5.64

-3.75

-66.49%

Provisions and contingencies

0.00

Profit After Tax

6.15

24.27

-18.12

-74.66%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

6.15

24.27

-18.12

-74.66%

Share in Profit of Associates

0.00

Minority Interest

0.00

0.39

-0.39

-100.00%

Other related items

0.00

Consolidated Net Profit

6.15

24.66

-18.51

-75.06%

Equity Capital

0.00

Face Value

1.00

0.00

Reserves

178.95

384.84

-205.89

-53.50%

Earnings per share (EPS)

0.22

2.31

-2.09

-90.48%

Diluted Earnings per share

0.22

2.31

-2.09

-90.48%

Operating Profit Margin (Excl OI)

2.86%

21.07%

0.00

-18.21%

Gross Profit Margin

13.57%

27.61%

0.00

-14.04%

PAT Margin

3.01%

15.37%

0.00

-12.36%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 20.47 Million

in Mar 2025

Figures in Million

QoQ Growth in quarter ended Mar 2025 is 6.61% vs 4.12% in Dec 2024

YoY Growth in quarter ended Mar 2025 is 15.39% vs 25.02% in Mar 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 0.62 Million

in Mar 2025

Figures in Million

QoQ Growth in quarter ended Mar 2025 is 1,650.00% vs -103.17% in Dec 2024

YoY Growth in quarter ended Mar 2025 is 342.86% vs 120.59% in Mar 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 2.56 Million

in Mar 2025

Figures in Million

QoQ Growth in quarter ended Mar 2025 is 6.67% vs -19.73% in Dec 2024

YoY Growth in quarter ended Mar 2025 is 24.88% vs 102.97% in Mar 2024

Quarterly - Interest

Interest 0.23 Million

in Mar 2025

Figures in Million

QoQ Growth in quarter ended Mar 2025 is -47.73% vs 62.96% in Dec 2024

YoY Growth in quarter ended Mar 2025 is -8.00% vs 13.64% in Mar 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 2.86%

in Mar 2025

Figures in %

QoQ Growth in quarter ended Mar 2025 has improved from Dec 2024

YoY Growth in quarter ended Mar 2025 has improved from Mar 2024